SMT announces completion of patient enrolment of EverOCT Trial

Mumbai : SMT has announced the enrolment completion of EverOCT – Tetrilimus Optical Coherence Tomography (OCT) Study.

EverOCT study aims to evaluate the mal-apposition, degree of strut coverage and vessel wall response by OCT analysis after implantation of the biodegradable-polymer coated Tetrilimus Everolimus-eluting stent (EES). This would also be compared with the Quantitative Coronary Analysis (QCA) of the angiograms done at the time of OCT in a corelab. The study has been conducted under the leadership and principal investigator Prof Upendra Kaul. Dr Kaul is one of the pioneers in the interventional cardiology space in India. OCT analysis will be conducted at Cardiovascular Research Centre (CRC), under the direction of Dr. Alexandre Abizaid, (MD, PhD), Chairman of CRC and Director, Interventional Cardiology Institute of Dante Pazzanese de Cardiologia, São Paulo, Brazil.

“We look forward to seeing the conclusive outcomes of the EverOCT trial. We expect it will confirm the promising results we have seen so far. This Study involved enrolments of 57 patients at 7 sites spread across 5 states of the nation. We thank all the study collaborators for their support in recruiting patients.” said Prof Kaul, Principle Investigator of the EverOct Trial.

“We reiterate our position that Evidence Based Medicine will always be at the core of SMT’s product development strategy. EverOCT study puts us one step forward. Our vision is to be the therapy leader in cardiac interventional devices space while striving to bring innovative medical devices which will provide better therapy solutions.” added Mr Piyush Savalia, Sr. V.P. Clinical Trial, SMT. He further says that “We leverage a decade long healing experience while bringing the best of efficacy and safety outcomes offered through SMT DES.”

Tetrilimus is the 4th Generation stent system from SMT and the trend set by SMT has been followed by several players in the industry, owing to the clinical benefits of this innovative shift from the conventional durable polymers to biodegradable polymers. In collaboration with leading interventional cardiologists and researchers worldwide, SMT offers comprehensive range of innovative medical devices to address the cardiovascular treatment needs.

  • Related Posts

    Queer Tale of Transplant in Sir Ganga Ram, Recipient- to- be turns Donor

    New Delhi: It is a bizarre twist in the tale of organ transplant in Sir Ganga Ram hospital none had imagined. Fate intervened and turned the tale upside down. The…

    Brain Dead Youth’s Organs proved Manna from ‘Aakash’ saving 5 lives

    New Delhi: As 18 year old boy cruised heavenward, windfall of lives followed in Aakash Healthcare. In his death from a fatal accident, the boy became the reason for gift…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down